Clinical researchers are evaluating the real-world effectiveness of a novel immunotherapy agent versus standard chemotherapy in patients with stage IV non-small cell lung cancer. The study is a prospective observational cohort. The primary endpoint is overall survival, which is defined as the time from the initiation of therapy until death from any cause. Patients who are still alive at the end of the five-year study period, or who are lost to follow-up prior to that time, are censored in the analysis. Because treatment assignment was not randomized, the investigators must statistically adjust for significant baseline differences observed between the two treatment arms. Specifically, they need to control for patient age, baseline Eastern Cooperative Oncology Group (ECOG) performance status, and lifetime pack-years of smoking. Which of the following statistical methods is most appropriate to evaluate the primary endpoint in this study?
- Cox proportional hazards regressionAnswer
- BLog-rank test
- CMultiple logistic regression
- DAnalysis of covariance (ANCOVA)
- EMantel-Haenszel test